March 20, 2017

FocalSpec makes it to millions

In the pharmaceutical industry, the ability to measure surfaces with great accuracy is crucial.
In the pharmaceutical industry, the ability to measure surfaces with great accuracy is crucial.
Istockphoto.com/shironosov

Finnish FocalSpec, which specialises in roughness measurement, has raised 3.5 million euros in funding for business development.

FocalSpec’s Line Confocal Imaging (LCI) technology is challenging the position of the laser, which has been the most commonly used measuring technology in quality control.

The funding was granted by VTT Ventures, Nordic Option, Veritas Pension Insurance and a group of private investors from Finland and China. The money enables FocalSpec to scale up its operations.

FocalSpec’s current customer base include global corporations in consumer and mobile electronics, as well as the plastic and pharmaceutical industries.

“For a small startup, such significant funding enables us to scale up and grow our operation,” says Sauli Törmälä, president of FocalSpec. “First and foremost, this funding is a sign of FocalSpec’s international credibility. We have crucial expertise in our industry on the roughness measurement of transparent surfaces, for example.”

According to Törmälä, FocalSpec will double its number of employees within a year.

FocalSpec is based in Oulu, Finland, and has business operations in Europe, Asia and the United States.

Share: